Switch to:
Hi-Tech Pharmacal Co., Inc. (NAS:HITK)
Cash from Financing
$4.6 Mil (TTM As of Jan. 2014)

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Jan. 2014, Hi-Tech Pharmacal Co., Inc. received $1.4 Mil more from issuing new shares than it paid to buy back shares. It received $0.0 Mil from issuing more debt. It paid $0.0 Mil more to buy back preferred shares than it received from issuing preferred shares. It received $0.0 Mil from paying cash dividends to shareholders. It received $0.1 Mil on other financial activities. In all, Hi-Tech Pharmacal Co., Inc. earned $1.5 Mil on financial activities for the three months ended in Jan. 2014.


Definition

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Hi-Tech Pharmacal Co., Inc.'s Cash from Financing for the fiscal year that ended in Apr. 2013 is calculated as:

Cash from Financing(A: Apr. 2013 )
=Net Issuance of Stock+Net Issuance of Debt+Net Issuance of Preferred+Dividends+Other Financing
=0+-0.355+0+-20.176+8.498
=-12.0

Hi-Tech Pharmacal Co., Inc.'s Cash from Financing for the quarter that ended in Jan. 2014 is

Hi-Tech Pharmacal Co., Inc. Cash Flow from Financing for the trailing twelve months (TTM) ended in Jan. 2014 was -1.009 (Apr. 2013 ) + 0.316 (Jul. 2013 ) + 3.827 (Oct. 2013 ) + 1.491 (Jan. 2014 ) = $4.6 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

Cash from financing contains five items:

1. Net Issuance of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. If this number is positive, it means that the company has received more cash from issuing shares than it has paid to buy back shares. If this number is negative, it means that company has paid more cash to buy back shares than it has received for issuing shares.

Hi-Tech Pharmacal Co., Inc.'s net issuance of stock for the three months ended in Jan. 2014 was $1.4 Mil. Hi-Tech Pharmacal Co., Inc. received $1.4 Mil more from issuing new shares than it paid to buy back shares.

2. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Hi-Tech Pharmacal Co., Inc.'s net issuance of debt for the three months ended in Jan. 2014 was $0.0 Mil. Hi-Tech Pharmacal Co., Inc. received $0.0 Mil from issuing more debt.

3. Net Issuance of Preferred:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Hi-Tech Pharmacal Co., Inc.'s net issuance of preferred for the three months ended in Jan. 2014 was $0.0 Mil. Hi-Tech Pharmacal Co., Inc. paid $0.0 Mil more to buy back preferred shares than it received from issuing preferred shares.

4. Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Hi-Tech Pharmacal Co., Inc.'s cash flow for dividends for the three months ended in Jan. 2014 was $0.0 Mil. Hi-Tech Pharmacal Co., Inc. received $0.0 Mil from paying cash dividends to shareholders.

5. Other Financing:
Money spent or earned by company from other financial activities.

Hi-Tech Pharmacal Co., Inc.'s other financing for the three months ended in Jan. 2014 was $0.1 Mil. Hi-Tech Pharmacal Co., Inc. received $0.1 Mil on other financial activities.


Related Terms

Cash Flow from Operations, Cash Flow from Investing, Net Issuance of Stock, Net Issuance of Debt, Dividends, Net Issuance of Preferred


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Hi-Tech Pharmacal Co., Inc. Annual Data

Apr04Apr05Apr06Apr07Apr08Apr09Apr10Apr11Apr12Apr13
Net Issuance of Stock 23.8-6.43.0-11.4-1.5-1.60.00.00.00.0
Net Issuance of Debt -0.10.00.00.30.0-0.1-0.20.40.9-0.4
Net Issuance of Preferred 0.00.00.00.00.00.00.00.00.00.0
Dividends 0.00.00.00.00.00.00.00.00.0-20.2
Other Financing 0.00.00.00.50.50.616.32.14.18.5
Cash from Financing 23.7-6.43.0-10.7-1.1-1.216.12.55.1-12.0

Hi-Tech Pharmacal Co., Inc. Quarterly Data

Oct11Jan12Apr12Jul12Oct12Jan13Apr13Jul13Oct13Jan14
Net Issuance of Stock 0.61.70.02.02.42.20.00.33.81.4
Net Issuance of Debt 1.2-0.1-0.1-0.1-0.1-0.1-0.1-0.1-1.20.0
Net Issuance of Preferred 0.00.00.00.00.00.00.00.00.00.0
Dividends 0.00.00.00.00.0-20.20.00.00.00.0
Other Financing 0.42.0-1.30.61.01.2-0.90.11.20.1
Cash from Financing 2.23.6-1.42.63.3-16.9-1.00.33.81.5
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide